A New Approach for Diabetic Macular Edema Treatment: Review of Clinical Practice Results with 0.19 mg Fluocinolone Acetonide Intravitreal Implant Including Vitrectomized Eyes-Reference-Cited by-同舟云学术

A New Approach for Diabetic Macular Edema Treatment: Review of Clinical Practice Results with 0.19 mg Fluocinolone Acetonide Intravitreal Implant Including Vitrectomized Eyes

Published:2020-01-14 Issue:1 Volume:8 Page:1-10
ISSN:2167-4868
Container-title:Current Ophthalmology Reports
language:en
Short-container-title:Curr Ophthalmol Rep

Author:

Estebainha Raquel,Goldhardt Raquel,Falcão Manuel

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

http://link.springer.com/content/pdf/10.1007/s40135-020-00225-1.pdf

Reference45 articles.

1. The Diabetic Retinopathy Clinical Research Network. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;150218140025008.

2. Veritti D, Sarao V, Diplotti L, Samassa F, Lanzetta P. Fluocinolone acetonide for the treatment of diabetic macular edema. Expert Opin Pharmacother. 2017 Oct;18(14):1507–16.

3. Syed YY. Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN®): a review in diabetic macular edema. Drugs. 2017;77(5):575–83.

4. Haritoglou C, Mayer W, Wolf A. Fluocinolone acetonide for the treatment of diabetic macular edema. Expert Rev Clin Pharmacol. 2016;9(3):367–74. https://doi.org/10.1080/14656566.2017.1363182.

5. Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–64 Available from: http://care.diabetesjournals.org/cgi/doi/10.2337/dc11-1909.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Evidence of the Long-Term Effectiveness of 0.2 μg/Day Fluocinolone Acetonide Implant in Persistent and Recurrent Diabetic Macular Edema – A Single Center Study;Clinical Ophthalmology;2024-04

2. Retinal changes after fluocinolone acetonide implant (ILUVIEN®) for DME: SD-OCT imaging assessment using ESASO classification;European Journal of Ophthalmology;2023-07-20

3. Safety and effectiveness of the fluocinolone acetonide intravitreal implant (ILUVIEN): 3-year results from the European IRISS registry study;British Journal of Ophthalmology;2022-07-15

4. IL-17A Damages the Blood–Retinal Barrier through Activating the Janus Kinase 1 Pathway;Biomedicines;2021-07-16

5. Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema;Cells;2021-07-03